A Study of High-Dose Vit D Versus Standard of Care Vit D Supplementation

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

September 16, 2021

Primary Completion Date

February 21, 2024

Study Completion Date

August 15, 2024

Conditions
BreastBreast CancerOsteoporosis
Interventions
DIETARY_SUPPLEMENT

High Dose Vitamin D

High dose vitamin D: Subjects will receive 50,000 IU vitamin D2 weekly x 16 weeks followed by 4,000 IU of vitamin D3 daily with a goal 25(OH)D level of ≥45 but ≤80 ng/mL.

DIETARY_SUPPLEMENT

Standard of Care Vitamin D

Standard of Care Vitamin D: Vitamin D will be supplemented to 25(OH)D levels, with a goal 25(OH)D level of \>30 ng/mL according to Endocrine Society Practice Guidelines.

Trial Locations (1)

28204

Levine Cancer Institute, Charlotte

All Listed Sponsors
collaborator

Atrium Health Levine Cancer Institute

OTHER

lead

Wake Forest University Health Sciences

OTHER

NCT05016310 - A Study of High-Dose Vit D Versus Standard of Care Vit D Supplementation | Biotech Hunter | Biotech Hunter